Iran Ready to Tackle Biotechnology Sanctions: VP

Iran’s Vice President for Science and Technology Sorena Sattari says the country has specific plans to tackle sanctions, especially in the biotechnology sphere.

Iran will soon focus on a significant amount of support for medicine and vaccines needed for livestock and poultry, Sattari said during a visit to a knowledge-based company in the vicinity of Tehran.

He also announced the advancement of knowledge-based companies in biotechnology, human and animal medicine, and vaccines, adding that the young people who have ideas can, after a while, run knowledge-based companies and become a producer.

“We have great companies in this field, and we hope that this new move in the field of livestock and poultry will enable the country to be independent in producing medicines and vaccines,” said the vice president.

For a brief review of Iran’s achievements in various fields of science and technology, check the book “Science and Technology in Iran: A Brief Review – 2019

At the moment a good ecosystem has been created in this field turning the country into the first regional power in biotechnology, he added.

“We import $600 million worth of pharmaceuticals only in the human sphere annually, and we can produce 80 to 90 percent of it inside the country using the existing projects that are underway,” concluded Sattari.

   
   

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here

*